Read the paper: Digoxin for reduction of circulating tumor cell ... (or circulating cell-free fragments of tumour DNA) can detect cancer cells that remain in the body after treatment (termed ...

13, 2025 — Scientists have found that a test to detect circulating ... cancer cells from developing into tumors elsewhere in the ... Drug Improves Effectiveness of Radiation for Lung Cancer ...

Circulating tumor cells in locally advanced ... CTCs in locally advanced pancreatic cancer (LAPC). By assessing CTCs from peripheral blood prior to any treatment and after 2 months of chemotherapy ...

Sacituzumab govitecan—an ADC-targeting Trop-2—has shown tumor shrinkage in ... and platinum as first-line therapy for extensive-stage small-cell lung cancer: randomized, double-blind, phase ...

Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for ...

"During cancer treatment, apart from eliminating tumor cells, the senescent cells generated ... can be replicated in other tumor types such as lung cancer. "We want to assess whether this ...

Alan Tan spoke with CURE® about what patients with kidney cancer and providers who treat it may be able to learn from ctDNA. Among patients with metastatic renal cell carcinoma (mRCC), serial ...

lung or colon cancer brain metastases. "We hypothesize that the communication between neurons and cancer cells in the IPTO model favors the growth of central nervous system tumors, reflecting ...

making treatment more challenging. Standard cancer treatments focus on killing tumor cells but aren't specifically designed to stop metastasis. Circulating tumor cells — the cancer cells that ...

One of cancer’s ... by dissolving circulating clusters of breast cancer cells in patients. Radiation and chemotherapy are effective at combatting cancer, but tumors can “leak” cells into ...

particularly non-small cell lung cancer (NSCLC) and pancreatic cancer, according to results from a phase II study. Among 158 evaluable patients with 10 tumor types, 30% had an overall response ...

Chimeric antigen receptor (CAR) T-cell therapy ... tumors, however, the efficacy of CAR T-cell treatments has been limited and progress “more incremental,” Christian Hinrichs, MD, with Rutgers ...